Similar articles

Abstract: The protein tyrosine phosphatase 1B (PTP1B) is an important regulator of metabolism. The relationship between PTP1B and tumors is quite complex. The purpose of this study is to explore the expression pattern and role of PTP1B in breast cancer. The expression of PTP1B was detected in 67 samples of breast cancer tissue by Western blot. Cell growth assay, Transwell migration assay, and Scratch motility assay were used to examine the proliferation and migration of MCF-7 with and without PTP1B. The total levels and phosphorylated levels of signal transduction and activator of transcription 3 (STAT3) and the expression of C-C motif chemokine ligand 5 (CCL5) were also examined by Western blot. PTP1B was overexpressed in over 70% of breast cancer tissues, correlating with patients with estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and human epidermal growth factor receptor 2 (HER2)-positive tumors. The data also showed that both tumor size and lymph node metastasis were significantly higher in patients with a higher level of PTP1B. The proliferation and migration of MCF-7 cells were found to be inhibited after knocking down the gene of PTP1B. Our data also showed that PTP1B could up-regulate the dephosphorylated level of STAT3, which could increase the expression of CCL5. These phenomena indicated that PTP1B may play a crucial role in the development of breast cancer.

蛋白酪氨酸磷酸酶1B在乳腺癌进展中的作用

[1]ACS (American Cancer Society), 2010. Breast Cancer Facts & Figures 2009–2010. American Cancer Society, Atlanta, p.28.

[2]Arias-Romero, L.E., Saha, S., Villamar-Cruz, O., et al., 2009. Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells. Cancer Res., 69(11):4582-4588.

[3]Baselga, J., Norton, L., 2002. Focus on breast cancer. Cancer Cell, 1(4):319-322.

[4]Bence, K.K., Delibegovic, M., Xue, B., et al., 2006. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat. Med., 12(8):917-924.

[5]Bentires-Alj, M., Neel, B.G., 2007. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res., 67(6):2420-2424.

[6]Bjorge, J.D., Pang, A., Fujita, D.J., 2000. Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. J. Biol. Chem., 275(52):41439-41446.

[7]Boute, N., Boubekeur, S., Lacasa, D., et al., 2003. Dynamics of the interaction between the insulin receptor and protein tyrosine-phosphatase 1B in living cells. EMBO Rep., 4(3):313-319.

[8]Buffart, T.E., van Grieken, N.C., Tijssen, M., et al., 2009. High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers. Virchows Arch., 455(3):213-223.

[9]Dubé, N., Tremblay, M.L., 2004. Beyond the metabolic function of PTP1B. Cell Cycle, 3(5):548-551.

[10]Dubé, N., Cheng, A., Tremblay, M.L., 2004. The role of protein tyrosine phosphatase 1B in Ras signaling. Proc. Natl. Acad. Sci. USA, 101(7):1834-1839.

[11]Dubé, N., Bourdeau, A., Heinonen, K.M., et al., 2005. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development. Cancer Res., 65(21):10088-10095.

[12]Fischer, E.H., Charbonneau, H., Tonks, N.K., 1991. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science, 253(5018):401-406.

[13]Julien, S.G., Dubé, N., Read, M., et al., 2007. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat. Genet., 39(3):338-346.

[14]Karnoub, A.E., Dash, A.B., Vo, A.P., et al., 2007. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature, 449(7162):557-563.

[15]Klaman, L.D., Boss, O., Peroni, O.D., et al., 2000. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol., 20(15):5479-5489.

[16]LaMontagne, K.R.Jr., Hannon, G., Tonks, N.K., 1998. Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of Rat-1 fibroblasts and promotes differentiation of K562 cells. Proc. Natl. Acad. Sci. USA, 95(24):14094-14099.

[17]Liu, F., Sells, M.A., Chernoff, J., 1998. Transformation suppression by protein tyrosine phosphatase 1B requires a functional SH3 ligand. Mol. Cell. Biol., 18(1):250-259.

[18]Mustelin, T., Feng, G.S., Bottini, N., et al., 2002. Protein tyrosine phosphatases. Front Biosci., 7:d85-d142.

[19]Nanney, L.B., Davidson, M.K., Gates, R.E., et al., 1997. Altered distribution and expression of protein tyrosine phosphatases in normal human skin as compared to squamous cell carcinomas. J. Cutan. Pathol., 24(9):521-532.

[20]Pinilla, S., Alt, E., Abdul Khalek, F.J., et al., 2009. Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion. Cancer Lett., 284(1):80-85.

[21]Scotto, L., Narayan, G., Nandula, S.V., et al., 2008. Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer, 47(9):755-765.

[22]Wang, J., Liu, B., Chen, X., et al., 2012. PTP1B expression contributes to gastric cancer progression. Med. Oncol., 29(2):948-956.

[23]Warabi, M., Nemoto, T., Ohashi, K., et al., 2000. Expression of protein tyrosine phosphatases and its significance in esophageal cancer. Exp. Mol. Pathol., 68(3):187-195.

[24]Woodford-Thomas, T.A., Rhodes, J.D., Dixon, J.E., 1992. Expression of a protein tyrosine phosphatase in normal and v-src-transformed mouse 3T3 fibroblasts. J. Cell Biol., 117(2):401-414.

[25]Yang, J., Stark, G.R., 2008. Roles of unphosphorylated STATs in signaling. Cell Res., 18(4):443-451.

[26]Yang, J., Chatterjee-Kishore, M., Staugaitis, S.M., et al., 2005. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res., 65(3):939-947.

[27]Yang, J., Liao, X., Agarwal, M.K., et al., 2007. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFκB. Genes Dev., 21(11):1396-1408.

[28]Zhang, Y., Yao, F., Yao, X., et al., 2009. Role of CCL5 in invasion, proliferation and proportion of CD44⁺/CD24⁻ phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression. Oncol. Rep., 21(4):1113-1121.

[29]Zhang, Y., Liao, S., Fan, W., et al., 2014. Tunicamycin-induced ER stress regulates chemokine CCL5 expression and secretion via STAT3 followed by decreased transmigration of MCF-7 breast cancer cells. Oncol. Rep., 32(6):2769-2776.

[30]Zhu, S., Bjorge, J.D., Fujita, D.J., 2007. PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res., 67(21):10129-10137.